Bench-to-clinic development of imageable drug-eluting ...
Herein, we describe the steps taken in the development of DC Bead LUMI™, the first commercially available radiopaque drug-eluting bead, ultimately leading to the first human experience of this novel …
BTG plc Announces CE Mark Certification For DC Bead LUMI, The ...
Mar 7, 2017 · About DC Bead LUMI™ DC Bead LUMI™ is the first commercially available radiopaque drug-eluting bead (DEB) which can be loaded with doxorubicin or irinotecan for the local treatment of …
BTG | DC Bead Drug-Eluting Bead
Feb 1, 2011 · Description From BTG DC Bead is an embolic Drug-Eluting Bead capable of loading and releasing in a controlled manner chemotherapeutic agents. DC Bead is used in trans-arterial …
간암, 약물 방출 미세구 (Drug eluting bead)를 사용한 경동맥 화학 …
May 26, 2022 · 시술 방법 약물 방출 미세구 (DC bead)를 이용한 경동맥 화학색전술 (TACE) 방법은 색전 물질을 제외하고 기본적으로 시술 준비는 TACE와 동일하지만 리피오돌 ( Lipiodol이) 아닌 미세구를 …
Boston Scientific DC | myHealthbox
Dec 30, 2010 · DC Bead LUMI™ can be used as an embolic agent with or without delivery of doxorubicin or irinotecan. Unloaded DC Bead LUMI™ is intended to be used for the embolisation of …
The use of DC bead particles loaded with doxorubicin for the ...
Background The use of DC Bead particles loaded with doxorubicin (DCBP-D) in hepatic chemoembolisation (HC), is presented as a first line option for non-curative treatment of multifocal …
Toward a better understanding of the mechanism of action for ...
DC Bead is designed for the embolization of liver malignancies combined with local sustained chemotherapy delivery. It was first demonstrated around a decade ago that irinotecan could be …